Enova International: The 'Pricey' Label Is Wrong — and the Forward Math Proves It

A recent headline called Enova International a "great business" but warned it "looks pricey." The first half of that claim is correct. The second half fails the math.

Enova (NYSE: ENVA) trades at 21 times forward earnings. On its own, that number looks like a premium price. But the company is delivering eight straight quarters of adjusted earnings-per-share growth for eight consecutive quarters — and raised full-year 2026 EPS guidance to 30–35% growth after crushing Q2. The PEG ratio (price-to-earnings divided by growth rate) sits at 0.40. That means the stock trades at less than half the multiple you'd expect for its growth rate. A stock where the growth rate is five times the PEG denominator is not pricey. It's a discount.

The market's focus on the headline P/E is the wrong variable. Here's what actually matters.

1. The EPS trajectory is compounding, not slowing.

Q2 2026 adjusted EPS was $4.31 per diluted share, up 33% from $3.23 a year prior — and 8.7% above the consensus estimate. Q1 was $3.87, also ahead of expectations. Adding the consensus estimates for the back half ($3.68 in Q3, $3.96 in Q4), the implied full-year adjusted EPS comes to roughly $15.82. At $253 per share, that's roughly 16x forward earnings.

Sixteen times earnings on a company growing EPS at 30% — let alone accelerating toward 35% — is not a stretched multiple. That's a GARP setup, and it's been one all year. The market priced Enova up from $103 to $253 over the past 12 months because the earnings machine kept delivering. The move up is a feature of the math, not a stretch beyond it.

2. Originations growth is the engine, and it's accelerating.

Total originations hit $2.3 billion in Q2, up 27% year-over-year. This marks the 11th straight quarter of originations growth at 20% or more. The total loan portfolio grew 28% to a record $5.5 billion. Small-business originations are the main driver — small-business revenue jumped 35% to $439 million, compared with 11% consumer growth. The company is transitioning from a pure consumer lender into a diversified consumer-plus-SMB platform, and the mix shift is improving revenue quality.

3. Credit quality is tightening, not deteriorating.

The consolidated net charge-off rate (the percentage of loans that aren't recovered, net of recoveries) fell to 7.3% in Q2 from 8.1% a year earlier. The net revenue margin expanded to 61% from 58%. Cost of funds dropped from 8.8% to 8.1%. These aren't cosmetic improvements — they reflect tighter underwriting, better real-time analytics, and a portfolio that's growing while losing less to defaults. The credit story, which has historically been the primary bear risk, is improving while the book expands.

4. The Grasshopper deal adds a 25% EPS floor to the long-term runway.

Enova announced in December 2025 that it would acquire Grasshopper Bancorp and its subsidiary Grasshopper Bank for $369 million in cash and stock. Management expects the deal to close in the second half of 2026, pending approval from the OCC and Federal Reserve. The strategic payoff is structural: Grasshopper brings a national bank charter, $3 billion in deposits, and deposit funding at 300–400 basis points below Enova's current securitization cost of funds.

On the earnings side, management projects first-year adjusted EPS accretion of over 15%, rising to more than 25% once synergies are fully realized. Enova's Q2 investor slides laid out year-three projected net synergies of $360 million — $360 million in revenue synergies and $150 million in funding synergies, with $360 million of net run-rate contribution after costs. That's not incremental revenue. That's structural margin expansion built on cheaper funding and a simplified regulatory framework.

Layering 25% EPS accretion on the implied $15.82 base pushes long-term adjusted EPS toward roughly $19.80. At the current share price, that's approximately 12.8x. A fintech lender growing revenue at 20%+ and delivering that multiple is a major bargain.

5. The $400 million buyback program is valuation support, not window dressing.

In November 2025, Enova's board authorized a $400 million share repurchase program — the largest in company history, running through June 2027. The company repurchased $19 million in Q2 alone. At a current market cap of $6.3 billion, the full $400 million authorization represents roughly 6% of equity. That's not a rounding error. It's management buying its own stock at prices far below where the earnings trajectory points.

The bear case and the break condition

The real risk is macro-driven credit deterioration. Enova's consumer segment carries a 12.8% net charge-off rate — higher than prime lending, which is expected for the subprime and near-prime book. A sharp economic downturn could push charge-offs higher, compress margins, and slow originations as borrowers strain. The portfolio is $5.5 billion and growing, so exposure is real.

If credit losses spike and originations decelerate below the 20% threshold the company has held for 11 consecutive quarters, the thesis breaks. That's the condition to watch.

The conclusion

Enova's stock has run from $103 to $253 over the past year. The price appreciation reflects the earnings trajectory, and it's easy to call the current level "rich" without doing the arithmetic. But the stock trades at roughly 16x forward earnings on 30%+ EPS growth, with a PEG of 0.40, and the Grasshopper acquisition pushes that multiple below 13x once synergies are realized. The forward math doesn't support the "pricey" label. It supports the opposite.